Gerd Kallischnigg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gerd Kallischnigg has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Rolf Weitkunat
Department of Biostatistics & Epidemiology, R&D, Philip Morris International, Neuchâtel, Switzerland
2 shared publications - Etienne Kaelin
Department of Biostatistics & Epidemiology, R&D, Philip Morris International, Neuchâtel, Switzerland
1 shared publication - Grégory Vuillaume
Department of Biostatistics & Epidemiology, R&D, Philip Morris International, Neuchâtel, Switzerland
1 shared publication - Peter Nicholas Lee
P.N. Lee Statistics and Computing Ltd., Sutton, UK
1 shared publication
Latest Publications
- Open Access
- 28 May 2010
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 10 (1) , 47
Effectiveness of strategies to increase the validity of findings from association studies: size vs. replication
The capacity of multiple comparisons to produce false positive findings in genetic association studies is abundantly clear. To address this issue, the concept of false positive report probability (FPRP) measures "the probability of no true association between a genetic variant and disease given a statistically significant finding". This concept involves the notion of prior probability of an association between a genetic variant and a disease, making it difficult to achieve acceptable levels for the FPRP when the prior probability is low. Increasing the sample size is of limited efficiency to improve the situation.
- 28 May 2010
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 10 (1) , 47
Open AccessEffectiveness of strategies to increase the validity of findings from association studies: size vs. replication
The capacity of multiple comparisons to produce false positive findings in genetic association studies is abundantly clear. To address this issue, the concept of false positive report probability (FPRP) measures "the probability of no true association between a genetic variant and disease given a statistically significant finding". This concept involves the notion of prior probability of an association between a genetic variant and a disease, making it difficult to achieve acceptable levels for the FPRP when the prior probability is low. Increasing the sample size is of limited efficiency to improve the situation.
- Open Access
- 1 May 2008
- Published by Springer Nature in BMC Oral Health
- Vol. 8 (1) , 13
Systematic review of the relation between smokeless tobacco and non-neoplastic oral diseases in Europe and the United States
How smokeless tobacco contributes to non-neoplastic oral diseases is unclear. It certainly increases risk of oral mucosal lesions, but reviewers disagree as to other conditions. In some areas, especially South-East Asia, risk is difficult to quantify due to the many products, compositions (including non-tobacco ingredients), and usage practices involved. This review considers studies from Europe (in practice mainly Scandinavia) and from the USA.
- 1 May 2008
- Published by Springer Nature in BMC Oral Health
- Vol. 8 (1) , 13
Open AccessSystematic review of the relation between smokeless tobacco and non-neoplastic oral diseases in Europe and the United States
How smokeless tobacco contributes to non-neoplastic oral diseases is unclear. It certainly increases risk of oral mucosal lesions, but reviewers disagree as to other conditions. In some areas, especially South-East Asia, risk is difficult to quantify due to the many products, compositions (including non-tobacco ingredients), and usage practices involved. This review considers studies from Europe (in practice mainly Scandinavia) and from the USA.